Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus Imatinib Mesylate in Postmenopausal ER/PR+ Metastatic Breast Cancer
NCT00338728Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2003
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2003; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00338728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338728.